-
Pluslife Featured in GenomeWeb and 360Dx Coverage on WHO’s New nPOC-NAAT Class for TB
We are pleased to see Pluslife featured in GenomeWeb coverage, with the article also appearing on its diagnostics-focused platform, 360Dx.
넶42 2026-03-20 -
Pluslife Founder Zhou Songyang Named to the 2026 TIME100 Health List
TIME has named Zhou Songyang, founder of Pluslife, to the 2026 TIME100 Health list.
넶107 2026-02-14 -
WHO Describes NPOC-NAATs as a New Diagnostic Class for TB Using Sputum and Tongue Swabs, Pluslife Named in WHO First-in-Class Test Description
WHO has published a policy page describing NPOC-NAATs as a new diagnostic class for TB detection using sputum and tongue swabs, and in its first-in-class test description identifies Pluslife’s MiniDock MTB Test as the product for which eligible data met the performance criteria used to establish the class.
넶321 2026-02-27 -
Pluslife Near Point-of-Care TB Test Added to the Stop TB Partnership’s Global Drug Facility (GDF) Diagnostics Portfolio
TB REACH-supported partners have already started piloting the use of the Pluslife MiniDock system in Cameroon, Bangladesh, Nigeria, and Vietnam, including community-based events delivering testing at point-of-care.
넶226 2026-01-20 -
Devex Op-Ed Highlights Pluslife MiniDock in Global South TB Diagnostic Innovations
The article discusses how high TB burden countries are under growing pressure as international aid declines, and argues that affordable diagnostic tools developed in the global south are essential to close the TB testing gap and save lives.
넶153 2025-11-24 -
Pluslife MiniDock TB Test Featured in 360Dx Article on Novel TB Diagnostics
Pluslife MiniDock TB test was featured in a recent 360Dx article on novel TB diagnostics, where it was described as a highly portable, battery operable near point-of-care system that may help expand access to TB testing.
넶151 2025-11-24
